Lost Money on Viking Therapeutics, Inc. (VKTX)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Viking Therapeutics, Inc. (VKTX) for potential federal securities law violations. Despite positive trial data for its anti-obesity drug VK2735, which boosted the stock by 9% on November 4, 2024, the investigation could impact investor sentiment.
November 12, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Viking Therapeutics is under investigation by Levi & Korsinsky for potential securities law violations. This comes after a 9% stock price increase due to positive trial data for their anti-obesity drug VK2735.
The investigation by Levi & Korsinsky into potential securities law violations could negatively impact investor confidence in Viking Therapeutics, despite recent positive trial data that boosted the stock. Legal issues often lead to stock volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100